High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer

BACKGROUND: Triple-negative breast cancer (TNBC) is a heterogeneous subtype of breast cancer that is prone to recurrence and metastasis with worse prognosis. Epirubicin-based chemotherapy is of great importance for patients with TNBC, but resistance to epirubicin severely limits the application of t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Onco Targets Ther
Hlavní autoři: Han, Tao, Liu, Zhaozhe, Li, Hengyu, Xie, Wanqing, Zhang, Ranran, Zhu, Li, Guo, Fang, Han, Yaling, Sheng, Yuan, Xie, Xiaodong
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2015
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4500622/
https://ncbi.nlm.nih.gov/pubmed/26185453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S81214
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky